HBM Healthcare Investments (HBMN)

Switzerland
Currency in CHF
183.20
-1.00(-0.54%)
Closed
HBMN Scorecard
Full Analysis
Management has been aggressively buying back shares
High dividend Yield
Fair Value
Day's Range
182.60185.40
52 wk Range
161.80214.00
Key Statistics
Edit
Bid/Ask
181.60 / 185.00
Prev. Close
184.2
Open
185
Day's Range
182.6-185.4
52 wk Range
161.8-214
Volume
4.48K
Average Vol. (3m)
7.41K
1-Year Change
-3.05%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HBMN Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
233.50
Upside
+27.46%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

HBM Healthcare Investments Company Profile

HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds, it invests in venture capital funds. It also seeks to finance spin-offs of product lines or departments from larger corporations and the expansion or restructuring of established companies, seed stages, venture capital, expansion capital stages, spin-offs, and buyouts. The fund prefers to invest in the private and public companies in the healthcare sector with a focus on human medicine, drugs, pharma , biopharma, biotechnology, diagnostics, medical technology, and related industries. It seeks to make initial investments in companies whose primary products are in clinical development or the immediately preceding stage. The fund typically invests globally with a focus on Asia Pacific, Asia, North America, and Europe. In case of public companies, it focuses on those which originate from its private portfolio. The fund increases its investment in portfolio companies by participating in a follow-on financing or after the portfolio company’s IPO. It may acquire majority participations in portfolio companies, usually takes a seat on the portfolio company’s Board of Directors, and largely makes equity investments but may also invest through other instruments including convertible bonds, debt securities, structured products, and derivatives. The fund exits its portfolio companies through trade sale or IPO.

Compare HBMN to Peers and Sector

Metrics to compare
HBMN
Peers
Sector
Relationship
P/E Ratio
5.6x8.5x8.9x
PEG Ratio
0.020.100.03
Price / Book
0.7x0.9x1.0x
Price / LTM Sales
5.5x7.5x2.7x
Upside (Analyst Target)
26.8%67.0%16.4%
Fair Value Upside
Unlock23.8%3.1%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 233.50
(+27.46% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 32.60%
Dividend Yield
4.07%
Industry Median 0.84%
Annualized Payout
7.50
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jan 20, 2025
EPS / Forecast
6.47 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

253.50
ALSN
+0.80%
246.00
BEKN
-0.81%
12.50
VLRT
0.00%

FAQ

What Is the HBM Healthcare Investments (HBMN) Stock Price Today?

The HBM Healthcare Investments stock price today is 183.20

What Stock Exchange Does HBM Healthcare Investments Trade On?

HBM Healthcare Investments is listed and trades on the Switzerland stock exchange.

What Is the Stock Symbol for HBM Healthcare Investments?

The stock symbol for HBM Healthcare Investments is "HBMN."

Does HBM Healthcare Investments Pay Dividends? What’s The Current Dividend Yield?

The HBM Healthcare Investments dividend yield is 4.09%.

What Is the HBM Healthcare Investments Market Cap?

As of today, HBM Healthcare Investments market cap is 1.24B.

What is HBM Healthcare Investments Earnings Per Share?

The HBM Healthcare Investments EPS is 32.60.

What Is the Next HBM Healthcare Investments Earnings Date?

HBM Healthcare Investments will release its next earnings report on May 15, 2025.

From a Technical Analysis Perspective, Is HBMN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.